This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Anthony Csóka: Innovator in Cancer Treatment
Introduction
Anthony Csóka is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and discoveries. His work focuses on the use of human plasma hyaluronidase in cancer therapy, which has the potential to improve treatment outcomes for tumor-bearing patients.
Latest Patents
Anthony Csóka holds a patent for the "Use of human plasma hyaluronidase in cancer treatment." This invention is based on the discovery of methods for the purification of an acid-active hyaluronidase found in human plasma (hpHAse). The patent includes both biochemical and immunoaffinity purification methods. The immunoaffinity purification method is particularly noteworthy as it identifies antibodies that specifically bind to native hpHAse, known as anti-native hpHAse antibodies. Additionally, the invention features an assay for the sensitive detection of HAse activity using biotinylated hyaluronic acid (bHA). The purification and characterization of hpHAse led to the discovery that it is encoded by the LuCa-1 gene, located on human chromosome 3p21.3, a region associated with tumor suppression. The invention also outlines methods for treating tumor-bearing patients through the administration of hpHAse and/or transformation of cells with hpHAse-encoding DNA. Anthony Csóka has 1 patent to his name.
Career Highlights
Anthony Csóka is affiliated with the University of California, where he conducts his research and development work. His innovative approach to cancer treatment has garnered attention in the scientific community, and his findings have the potential to pave the way for new therapeutic strategies.
Collaborations
Anthony has collaborated with notable colleagues, including Robert Stern and Gregory I Frost. Their combined expertise has contributed to the advancement of research in the field of cancer treatment.
Conclusion
Anthony Csóka is a pioneering inventor whose work in the use of human plasma hyaluronidase for cancer treatment represents a significant advancement in medical research. His contributions have the potential to enhance treatment options for patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile